Hetero Drugs

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Hetero Drugs Limited
Private
Industry Pharmaceuticals
Founded 1993
Headquarters Hyderabad, India
Key people
Dr. Bandi Parthasaradhi Reddy
Products Pharmaceuticals
Number of employees
Over 15,000
Subsidiaries Hetero Windpower
Website www.heteroworld.com

Hetero Drugs Limited is an Indian Pharmaceutical Company established in 1993. Hetero Drugs Limited founded by Dr. B. Parthasaradhi Reddy.[1]

Operations[edit]

Hetero has revenues of approximately $2.0 billion.[2] Hetero group employs over 15,000 people.[3] Hetero is a player in the API (Active Pharmaceutical Ingredients) market and finished dosages.[4] It has marketing presence in over 100 countries.

Hetero has supplied antiretroviral drugs to patients across 125 countries.[5]

Today, oseltamivir (Tamiflu) is also indicated for A[H1N1] virus, also known as swine flu.[citation needed]

Hetero also produces hepatitis C antivirals such as Sofovir (sofosbuvir) and Ledifos (a fixed-dose combination of sofosbuvir and ledipasvir).[citation needed]

Company Structure[edit]

Hetero Drugs Limited is the parent company in the Hetero group of companies and other companies which are part of the group are Hetero Labs, Hetero Research Foundation, Genx Laboratories and also foreign subsidiaries such as Camber pharma Inc., in USA and Richmond Labs in Argentina. The group is also investing in the wind power industry with a goal to reach 1000 Megawatts by 2017.[6]

2009 flu outbreak[edit]

In 2009, as the swine flu outbreak was spreading across the globe and various health organizations and government agencies were piling up stocks of oseltamivir as precautionary measures, Hetero supplied the generic oseltamivir under its brand name fluvir.[7]

Hetero delivered 10 million doses of generic Tamiflu to the Indian government in May 2009,[8] and shipped about 80 million doses to over 60 countries.[9]

Hetero received its second order from Indian government to supply another 10 million doses of generic Tamiflu in August 2009.[10]

Violations of FDA Regulations[edit]

In 2017, an FDA inspection of a Hetero drug manufacturing facility found several violations of cGMP regulations, recommended that Hetero hire a consultant to resolve questions of quality control, and ordered reports on each of its products that were to be exported into the United States.[11]

References[edit]

  1. ^ "Archived copy". Archived from the original on 23 April 2012. Retrieved 6 June 2012. 
  2. ^ "Hetero Drugs Limited." n.d. Company Information, EBSCOhost (accessed 8 October 2016 via University of Arizona proxy).
  3. ^ "STADA: STADA and Indian pharmaceutical company Hetero sign letter of intent for the founding of a contractual joint venture". Stada. 26 March 2015. Retrieved 22 June 2018. 
  4. ^ "Archived copy". Archived from the original on 2016-09-16. Retrieved 2016-07-11. 
  5. ^ ":: Welcome to Hetero ::". Heterodrugs.com. Archived from the original on 2014-01-17. Retrieved 2014-01-11. 
  6. ^ "Hetero Windpower". Hetero. Retrieved 22 June 2018. 
  7. ^ [1] Archived 30 April 2009 at the Wayback Machine.
  8. ^ Khomba Singh, ET Bureau 5 May 2009, 12.03am IST (2009-05-05). "Hetero bags mega chunk of govt's anti-flu drug deal - Economic Times". Economictimes.indiatimes.com. Retrieved 2014-01-11. 
  9. ^ "Hyderabad pharma cos cash in on Swine-Flu fever". Moneycontrol.com. Retrieved 2014-01-11. 
  10. ^ Khomba Singh, ET Bureau 22 August 2009, 03.02am IST (2009-08-22). "Hetero bags deal for 10 m Tamiflu - Economic Times". Economictimes.indiatimes.com. Retrieved 2014-01-11. 
  11. ^ Cosgrove, Thomas (15 August 2017). "Hetero Labs Limited Unit V 8/15/17". FDA.